This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2025 summit

De-Risking Per-Patient Economics & Investment for Personalized Cancer Vaccines to Secure Phase III-Ready Capital & Accelerate Market Entry

By | 5 February 2026